FN Clarivate Analytics Web of Science
VR 1.0
PT J
ER

PT J
ER

PT J
ER

PT J
DE Calves; Prenatal Stress; DNA Methylation
ER

PT J
DE Prenatal exome; Variants of unknown clinical significance; Phenotyping
ID CHROMOSOMAL MICROARRAY; CHARGE SYNDROME; DISORDERS; FETUSES;
   ABNORMALITIES; ULTRASOUND; DISCOVERY; STANDARDS; MUTATION; DISEASE
ER

PT J
DE cell-free DNA sequencing; copy-number variant; incidental finding;
   prenatal screening; sex-chromosome aneuploidy
ID SEX-CHROMOSOME ANEUPLOIDY; COPY-NUMBER VARIATION; PLASMA DNA;
   NONINVASIVE DETECTION; FETAL ANEUPLOIDY; PREGNANT-WOMEN; MOSAICISM;
   DUPLICATION; EXPERIENCE; TRANSPLANT
ER

PT J
ID NONINVASIVE PRENATAL-DIAGNOSIS; MATERNAL PLASMA DNA; FETAL ANEUPLOIDY;
   INCIDENTAL DETECTION; POSITION STATEMENT; IMPACT; DISORDERS; FRACTION;
   HEALTH
ER

PT J
DE Prenatal diagnosis; NIPT; Cell free fetal DNA; Aneuploidy
ID MATERNAL PLASMA DNA; CHROMOSOMAL MICROARRAY; ABNORMALITIES; BLOOD;
   DISORDERS; FETUSES
ER

PT J
DE Prenatal diagnosis; Monogenic disorders; Non-invasive prenatal
   diagnosis; Cell-free fetal DNA; Single gene disorders; Exome sequencing;
   Fetal abnormalities
ID RELATIVE HAPLOTYPE DOSAGE; PRENATAL-DIAGNOSIS; MATERNAL PLASMA;
   BETA-THALASSEMIA; CONGENITAL-ANOMALIES; COST-ANALYSIS; DNA; MUTATION;
   FETUSES; NIPT
ER

PT J
ID NONINVASIVE PRENATAL-DIAGNOSIS; FETAL RHD STATUS; MATERNAL PLASMA; DNA;
   CELL; SERUM; WOMEN; MOTHER; FETUS; BLOOD
ER

PT J
DE Cell-free deoxyribonucleic acid (cfDNA); Down syndrome; Fetus; Genetics;
   Noninvasive prenatal testing; Prenatal; Screening
ID CLINICAL-LABORATORY-EXPERIENCE; NONINVASIVE PRENATAL DETECTION; SEX
   CHROMOSOMAL ANEUPLOIDIES; COMMON FETAL ANEUPLOIDIES; MATERNAL
   BODY-FLUIDS; EPIDEMIOLOGIC FINDINGS; PLACENTAL MOSAICISM; NUCLEIC-ACIDS;
   UNITED-STATES; PLASMA
ER

PT J
DE genetic diagnosis; hemophilia B; Karyomapping; preimplantation genetic
   diagnosis; prenatal diagnosis
ID FACTOR-IX; MUTATIONS; ACTIVATION; GUIDELINES; INHIBITORS; SEQUENCE;
   DISEASE
ER

PT J
DE Infant; premature; Gastrointestinal microbiome; Anti-bacterial agents;
   High-throughput nucleotide sequencing; Intensive care unit; neonatal
ID BACTERIAL COMMUNITY STRUCTURE; INTESTINAL MICROBIOTA;
   CLOSTRIDIUM-DIFFICILE; COLONIZATION; EPIDEMIOLOGY; NEWBORNS; SEPSIS;
   BIRTH
ER

PT J
DE Genomics; expanded carrier screening; cell free DNA; chromosomal
   microarray; exome sequencing
ID PRENATAL-DIAGNOSIS
ER

PT J
ID FREE FETAL DNA; CLINICAL-PRACTICE; PHENYLKETONURIA; FAMILY; CHINA
ER

PT J
DE Prenatal diagnosis; next-generation sequencing; noninvasive prenatal
   diagnosis; monogenic disorders; cell-free fetal DNA; single gene
   disorders; exome sequencing; fetal abnormalities
ID FREE FETAL DNA; SINGLE-GENE DISORDERS; CELL-FREE DNA; RELATIVE HAPLOTYPE
   DOSAGE; MATERNAL PLASMA; CYSTIC-FIBROSIS; DIAPHRAGMATIC-HERNIA;
   MOLECULAR-PATHOLOGY; MONOGENIC DISORDERS; INCIDENTAL FINDINGS
ER

PT J
DE Fetal overgrowth; GPC3; Prenatal symptoms; Simpson-Golabi-Behmel
   syndrome; Ultrasound
ID BECKWITH-WIEDEMANN-SYNDROME; INCREASED NUCHAL TRANSLUCENCY;
   PALLISTER-KILLIAN-SYNDROME; PERLMAN SYNDROME; SOTOS-SYNDROME; DIAGNOSIS;
   ULTRASOUND; FETUSES; GENE; ABNORMALITIES
ER

PT J
DE noninvasive prenatal testing; copy number variation; cell-free fetal DNA
ID CHROMOSOMAL ANEUPLOIDIES; DIAGNOSIS; DNA
ER

PT J
ID MATERNAL CELL CONTAMINATION; GENETIC DIAGNOSIS; EXOME; ABNORMALITIES;
   MUTATIONS; CHALLENGES; ANEUPLOIDY; DISORDERS; MOSAICISM; DISEASE
ER

PT J
ID CENANI-LENZ SYNDROME; PONTOCEREBELLAR HYPOPLASIA TYPE-1; PETERS PLUS
   SYNDROME; MUTATIONS; DISEASE; PROTEIN; IFT122; FAMILY; GENE; CILIOPATHY
ER

PT J
ID FREE FETAL DNA; CONGENITAL ADRENAL-HYPERPLASIA; RELATIVE HAPLOTYPE
   DOSAGE; MATERNAL PLASMA; BETA-THALASSEMIA; RECESSIVE DISORDERS; SEQUENCE
   VARIANTS; CLINICAL-PRACTICE; CYSTIC-FIBROSIS; COST-ANALYSIS
ER

PT J
DE Prenatal paternity testing; Cell-free fetal DNA; Massively parallel
   sequencing
ER

PT J
ID CELL-FREE DNA; CHROMOSOMAL MICROARRAY; MEDICAL-GENETICS;
   AMERICAN-COLLEGE; MATERNAL BLOOD; EXOME; ANEUPLOIDY; GUIDELINE;
   ANOMALIES; STATEMENT
ER

PT J
ER

PT J
ID CELL-FREE DNA; MATERNAL PLASMA; PERFORMANCE
ER

PT J
ER

PT J
ID CONGENITAL ADRENAL-HYPERPLASIA; HAPLOTYPE-BASED APPROACH; FREE FETAL
   DNA; BETA-THALASSEMIA; FEASIBILITY; VALIDATION; EXPERIENCE; DISEASES;
   FETUS; GENE
ER

PT J
ID ANAL MOTA SYNDROME
ER

PT J
DE thalassemia; noninvasive prenatal test; target region capture; massively
   parallel sequencing; SNP
ID MONOGENIC DISEASES; PLASMA; MUTATION; PCR
ER

PT J
ID ANEUPLOIDIES; RISK
ER

PT J
ID ANEUPLOIDY
ER

PT J
ID CELL-FREE DNA; NONINVASIVE PRENATAL-DIAGNOSIS; FETAL DNA; COPY NUMBER;
   ABERRATIONS; FRACTION; ORIGIN; CANCER
ER

PT J
DE High-throughput sequencing; sex chromosomal aneuploidies; noninvasive
   prenatal testing; prenatal diagnosis; prenatal screening; cffDNA
ID CELL-FREE DNA; CONFINED PLACENTAL MOSAICISM; CLINICAL-EXPERIENCE;
   TRISOMIES 21; POSITION STATEMENT; DIAGNOSIS; PLASMA; PREGNANCIES;
   INACTIVATION; ABNORMALITY
ER

PT J
DE choroideremia; DNA mutation; next-generation sequencing; non-invasive
   prenatal testing; cell-free fetal DNA; SRY gene
ID FREE FETAL DNA; MATERNAL PLASMA; RETINITIS-PIGMENTOSA; CANCER
   METASTASIS; GENE; MUTATIONS; FAMILIES; DISEASE; BLOOD; POPULATION
ER

PT J
DE non-invasive prenatal testing; monogenic diseases; aneuploidies;
   thalassemia; massively parallel sequencing; fetal DNA fractions
ID FREE FETAL DNA; CONGENITAL ADRENAL-HYPERPLASIA;
   POLYMERASE-CHAIN-REACTION; HAPLOTYPE-BASED APPROACH; WEEKS GESTATION
   RELATION; BETA-THALASSEMIA; MONOGENIC DISEASES; NUCLEIC-ACIDS;
   ANEUPLOIDY; MUTATIONS
ER

PT J
DE noninvasive prenatal testing; circulating cell-free DNA; fetal DNA
   fraction
ID MATERNAL PLASMA DNA; CELL-FREE DNA; CONGENITAL ADRENAL-HYPERPLASIA;
   HAPLOTYPE-BASED APPROACH; DIAGNOSIS; METHYLATION; ORIGIN; SERUM;
   TRANSPLANTATION; ANEUPLOIDY
ER

PT J
ID CONGENITAL ADRENAL-HYPERPLASIA; MATERNAL PLASMA; FETAL DNA; MONOGENIC
   DISEASES; BETA-THALASSEMIA; DIAGNOSIS; DISORDERS; BLOOD; SERUM
ER

PT J
ER

PT J
DE noninvasive prenatal testing; targeted sequencing; fetal DNA; massive
   parallel sequencing; fetal fraction
ID CELL-FREE DNA; SEX CHROMOSOMAL ANEUPLOIDIES; MATERNAL PLASMA; FETAL
   ANEUPLOIDIES; PERFORMANCE; VALIDATION; FRACTION
ER

PT J
ID EXPERIENCES; WOMEN
ER

PT J
ID UNITED-STATES; DISEASE
ER

PT J
ID FUTURE
ER

PT J
ID HEREDITARY BREAST; OVARIAN-CANCER
ER

PT J
ER

PT J
ID CELL-FREE DNA; DEPENDENT PROBE AMPLIFICATION; CONFINED PLACENTAL
   MOSAICISM; ANGELMAN-SYNDROMES; MATERNAL PLASMA; UNIPARENTAL DISOMY;
   FETAL DNA; MICRODELETION SYNDROMES; IMPRINTING MUTATIONS; MOLECULAR
   DIAGNOSIS
ER

PT J
ER

PT J
ID CHROMOSOMAL MICROARRAY; PRENATAL-DIAGNOSIS; ABNORMALITIES; ULTRASOUND;
   VARIANTS; FETUSES
ER

PT J
ID CELL-FREE DNA; COMPARATIVE GENOMIC HYBRIDIZATION; COPY-NUMBER VARIATION;
   SINGLE-NUCLEOTIDE POLYMORPHISMS; CHROMOSOMAL MICROARRAY ANALYSIS;
   POLYMERASE-CHAIN-REACTION; IN-VITRO FERTILIZATION; PREGNANCY FOLLOW-UP;
   MATERNAL PLASMA DNA; FREE FETAL DNA
ER

PT J
ID PREGNANCY; ASSAY
ER

PT J
ID CELL-FREE DNA; MATERNAL PLASMA; RISK
ER

PT J
ID FRACTION
ER

PT J
ID CELL-FREE DNA; COPY-NUMBER VARIATION; MATERNAL PLASMA; FETAL ANEUPLOIDY;
   TRISOMY 16; SUBCHROMOSOMAL ABNORMALITIES; SIZE DISTRIBUTIONS; DIAGNOSIS;
   PERFORMANCE; ABERRATIONS
ER

PT J
ID CHROMOSOMAL ANEUPLOIDIES; RARE MUTATIONS; FETAL DNA; ACHONDROPLASIA;
   COVERAGE; ACCURATE
ER

PT J
ID MATERNAL PLASMA; DNA; DIAGNOSIS; AMNIOCENTESIS; ANEUPLOIDY
ER

PT J
ER

PT J
DE Cell-free fetal DNA; Noninvasive prenatal screening; Next-generation
   sequencing; Multiple parallel shotgun sequencing; Selected probes;
   Selective sequencing; Single nucleotide polymorphisms; DNA methylation
ID NONINVASIVE-PRENATAL-DIAGNOSIS; MATERNAL PLASMA DNA; FREE FETAL DNA;
   CHROMOSOMAL ANEUPLOIDIES; 1ST TRIMESTER; DOWN-SYNDROME;
   PERIPHERAL-BLOOD; PREGNANT-WOMEN; ALLELIC RATIO; TRISOMIES 21
ER

PT J
ID NONINVASIVE PRENATAL-DIAGNOSIS; CONGENITAL ADRENAL-HYPERPLASIA;
   CELL-FREE DNA; CHROMOSOMAL ANEUPLOIDY; MONOGENIC DISEASES;
   PREGNANT-WOMEN; HUMAN GENOME; DIGITAL PCR; EFFICIENT; BLOOD
ER

PT J
ER

PT J
DE Case Reports; Genetics; Obstetrics; Prenatal Care
ID FETAL; ANEUPLOIDY; DIAGNOSIS
ER

PT J
DE cell-free DNA, (cfDNA); cell-free fetal DNA, (cffDNA); copy number
   variation, (CNV); genome sequencing; mosaicism; non-invasive prenatal
   testing, (NIPT); prenatal diagnosis
ID MATERNAL PLASMA DNA; CONFINED PLACENTAL MOSAICISM; CELL-FREE DNA; FREE
   FETAL DNA; NONINVASIVE PRENATAL-DIAGNOSIS; SEX CHROMOSOMAL ANEUPLOIDIES;
   TRISOMY NIFTY TEST; UNIPARENTAL DISOMY; GROWTH RESTRICTION; TWIN
   PREGNANCIES
ER

PT J
DE Gene; DNA; treatment; metabolism; rare; villus
ID METHYLMALONIC ACIDURIA
ER

PT J
ER

PT J
ER

PT S
ID CONGENITAL ADRENAL-HYPERPLASIA; EXPANDED TRISOMIES PROCEED; REAL-TIME
   PCR; MATERNAL PLASMA; SEX DETERMINATION; CYSTIC-FIBROSIS; MICRODELETION
   SYNDROMES; PREGNANT-WOMEN; HUNTINGTON-DISEASE; CLINICAL-PRACTICE
ER

PT S
ID CELL-FREE DNA; FREE FETAL DNA; INTRAUTERINE GROWTH RESTRICTION; SEX
   CHROMOSOMAL ANEUPLOIDIES; CONFINED PLACENTAL MOSAICISM; DOWN-SYNDROME;
   INTERNATIONAL SOCIETY; PREGNANT-WOMEN; WHOLE-GENOME; NONINVASIVE
   DIAGNOSIS
ER

PT J
DE Next Generation Sequencing; tyrosinemia; prenatal diagnosis; FAH gene
ID GENE; MUTATIONS; SPECTRUM
ER

PT S
DE noninvasive prenatal testing; methylome; transcriptome; next-generation
   sequencing; cell-free DNA
ID CELL-FREE DNA; FREE FETAL DNA; EARLY-ONSET PREECLAMPSIA; NONINVASIVE
   DETECTION; ANEUPLOIDY DETECTION; MONOGENIC DISEASES; CHROMOSOMES 13;
   TWIN ZYGOSITY; DOWN-SYNDROME; BLOOD
ER

PT J
DE noninvasive prenatal testing; NIPT; maternal plasma DNA; cell-free DNA;
   semiconductor sequencing
ID PRENATAL-DIAGNOSIS; RESOLUTION
ER

PT J
ID TRISOMY
ER

PT J
DE cell-free fetal DNA; digital PCR; massive parallel sequencing; maternal
   plasma; NIPT
ID CONGENITAL ADRENAL-HYPERPLASIA; FETAL CHROMOSOMAL ANEUPLOIDY;
   POLYMERASE-CHAIN-REACTION; COPY NUMBER ABERRATIONS; MATERNAL PLASMA;
   CLINICAL-EXPERIENCE; MONOGENIC DISEASES; PREGNANT-WOMEN; DIAGNOSIS; PCR
ER

PT J
ID SEVERE INTELLECTUAL DISABILITY; INCIDENTAL FINDINGS; WHOLE-EXOME;
   CHROMOSOMAL MICROARRAY; MENDELIAN DISORDERS; SECONDARY FINDINGS;
   CLINICAL-PRACTICE; PATIENT AUTONOMY; INFORMED-CONSENT; MATERNAL PLASMA
ER

PT J
DE Next generation sequencing; Bioinformatics analysis; Prenatal diagnosis;
   Cancer diagnosis
ID MATERNAL PLASMA DNA; NONINVASIVE PRENATAL-DIAGNOSIS; FETAL CHROMOSOMAL
   ANEUPLOIDY; COPY NUMBER ABERRATIONS; LUNG-CANCER PATIENTS;
   HEPATOCELLULAR-CARCINOMA; QUANTITATIVE-ANALYSIS; INCREASED INTEGRITY;
   SIZE DISTRIBUTIONS; COLORECTAL-CANCER
ER

PT J
ER

PT J
ID CHROMOSOMAL MICROARRAY; INCIDENTAL FINDINGS; ETHICAL-ISSUES; GENOME;
   RETURN; CHILDREN; PERIOD
ER

PT J
DE trisomy; aneuploidy; Down syndrome; screening; chromosomes;
   next-generation sequencing
ID IN-SITU HYBRIDIZATION; INCREASED NUCHAL TRANSLUCENCY; OF-THE-LITERATURE;
   QF-PCR; 1ST TRIMESTER; DOWN-SYNDROME; UNCULTURED AMNIOCYTES; FETAL
   ANEUPLOIDY; FOLLOW-UP; DIAGNOSIS
ER

PT J
DE aneuploidy screening; massive-parallel DNA sequencing; next-generation
   sequencing (NGS); non-invasive prenatal testing (NIPT)
ID MATERNAL PLASMA DNA; FREE FETAL DNA; CELL-FREE FETAL; SINGLE-GENE
   DISORDERS; CHROMOSOMAL ANEUPLOIDIES; 1ST TRIMESTER; DOWN-SYNDROME;
   BLOOD; TRISOMY-21; GENOME
ER

PT J
ID FREE FETAL DNA; MATERNAL PLASMA; BLOOD
ER

PT J
ID MELTING CURVE ANALYSIS; PRENATAL-DIAGNOSIS; PCR; DNA; PROBES;
   POLYMERIZATION; REVEALS
ER

PT J
ER

PT J
ER

PT J
DE array analysis; commercialization; massively parallel sequencing;
   noninvasive prenatal testing; prenatal; variants of unknown or uncertain
   clinical relevance
ID MATERNAL PLASMA DNA; CELL-FREE DNA; FETAL DNA; DIAGNOSIS
ER

PT J
DE cell-free DNA; fetal cells; fragmented DNA; genetic analysis; intact
   DNA; NIPT; noninvasive; nucleated red blood cells; prenatal diagnosis;
   trophoblasts
ID MATERNAL PERIPHERAL-BLOOD; CLINICAL-LABORATORY-EXPERIENCE;
   CHROMOSOME-ABNORMALITIES; ANEUPLOIDY DETECTION; TROPHOBLAST CELLS;
   GESTATIONAL-AGE; CERVICAL-MUCUS; PLASMA; SEX; 1ST-TRIMESTER
ER

PT J
ER

PT J
ER

PT J
ID FIBROBLAST-GROWTH-FACTOR; SINGLE-GENE DISORDERS; FACTOR RECEPTOR-3 GENE;
   FREE FETAL DNA; MATERNAL PLASMA; MUTATIONS; FGFR3; HYPOCHONDROPLASIA;
   CRANIOSYNOSTOSIS; IMPLEMENTATION
ER

PT J
DE next generation sequencing; cell-free DNA; non-invasive prenatal testing
ID CELL-FREE DNA; FREE FETAL DNA; MATERNAL PLASMA; MICROSATELLITE
   ALTERATIONS; SIZE DISTRIBUTIONS; CANCER PATIENTS; BLOOD; GENOME;
   DIAGNOSIS; SERUM
ER

PT J
ID MATERNAL PLASMA; SEQUENCING DATA; FETAL DNA
ER

PT J
DE array CGH limitations; molecular karyotyping; prenatal CNV-Seq
ID PRENATAL-DIAGNOSIS; VARIANTS
ER

PT J
ID PROTEIN-C DEFICIENCY
ER

PT J
ID CHROMOSOME REARRANGEMENTS; CATASTROPHIC EVENT; GERMLINE
ER

PT J
DE Amplification-free; Library preparation; Cell-free DNA; Karyotyping;
   Bias; Fetal aneuploidy
ID LIBRARY PREPARATION; FETAL ANEUPLOIDY; MATERNAL BLOOD; RARE MUTATIONS;
   ANCIENT
ER

PT J
DE Maternal plasma DNA; NIPT; sequencing; trisomy 9
ER

PT J
ID CELL-FREE DNA; CONGENITAL ADRENAL-HYPERPLASIA; PRENATAL-DIAGNOSIS;
   CHROMOSOMAL ANEUPLOIDY; MESSENGER-RNA; DIGITAL PCR; METHYLATION; GENE;
   IDENTIFICATION; POLYMORPHISMS
ER

PT J
ER

PT J
DE Prenatal diagnosis; chromosome abnormality; NIPT; microarray; genetic
   testing; next-generation sequencing; non-invasive prenatal testing
ID NONINVASIVE PRENATAL-DIAGNOSIS; CELL-FREE DNA; MATERNAL PLASMA; FETAL
   DNA; CHROMOSOMAL MICROARRAY; BLOOD-CELLS; GENETIC AMNIOCENTESIS;
   ANEUPLOIDY DETECTION; HYBRIDIZATION; ABNORMALITIES
ER

PT J
ID CHROMOSOMAL MICROARRAY; MUTATIONS; DIAGNOSIS; GENE; ULTRASOUND; FAMILIES
ER

PT J
ID DOWN-SYNDROME; CHROMOSOMAL-ABNORMALITIES; INTERNATIONAL SOCIETY;
   PRENATAL-DIAGNOSIS; HIGH-RISK; POPULATION; EXPERIENCE; AUSTRALIA;
   PREGNANCY; STATEMENT
ER

PT J
ER

PT J
DE depth of coverage; NGS; NIPT; noninvasive; prenatal; whole genome
   sequencing
ID CELL-FREE DNA; FREE FETAL DNA; SEX CHROMOSOMAL ANEUPLOIDIES; CONGENITAL
   ADRENAL-HYPERPLASIA; WEEKS GESTATION RELATION; MATERNAL PLASMA;
   DOWN-SYNDROME; SIZE DISTRIBUTIONS; PREGNANT-WOMEN; RHESUS D
ER

PT J
ER

PT J
ER

PT J
DE ARPKD; PKHD1; Compound heterozygous mutation; Prenatal diagnosis;
   Targeted exome sequencing
ID POLYCYSTIC KIDNEY-DISEASE; CLINICAL-EXPERIENCE; GENE; ENCODES; VARIANTS;
   RECEPTOR; PROTEIN
ER

PT J
ER

PT J
ID MATERNAL BLOOD; ANEUPLOIDY; DNA; CELLS
ER

PT J
ID MATERNAL PLASMA
ER

PT J
DE Congenital adrenal hyperplasia; Fetal DNA in maternal plasma; Haplotype;
   Massively parallel sequencing; Noninvasive prenatal testing
ID 21-HYDROXYLASE DEFICIENCY; MONOGENIC DISEASES; BETA-THALASSEMIA; FETAL
   DNA; DISORDERS; GENOME; PREGNANCIES; EXCLUSION; MUTATION; UPDATE
ER

PT J
DE size profiling; fetal aneuploidy; next-generation sequencing; Down
   syndrome; Turner syndrome
ID CELL-FREE DNA; FETAL CHROMOSOMAL ANEUPLOIDY; COPY NUMBER ABERRATIONS;
   MATERNAL PLASMA; CIRCULATING DNA; DIGITAL PCR; QUANTIFICATION;
   DISTRIBUTIONS; MUTATIONS; FRACTION
ER

PT J
ER

PT J
DE chromosomal aberrations; clinical practice; fetal DNA; next generation
   sequencing; noninvasive prenatal diagnostics
ID MATERNAL PLASMA; FETAL DNA; ABNORMALITIES; ANEUPLOIDY; SERUM
ER

PT J
DE Prenatal diagnosis; LDR microarray; Congenital deafness; Maternal plasma
   DNA
ID NONINVASIVE PRENATAL-DIAGNOSIS; FREE FETAL DNA; BETA-THALASSEMIA;
   MICROARRAY; GENE; UK
ER

PT J
ER

PT J
DE Whole genome sequencing; Next-generation sequencing; Noninvasive
   prenatal testing; Noninvasive prenatal diagnosis
ID DIAGNOSIS; MICROARRAY; MEDICINE; HEALTH
ER

PT J
ER

PT J
ER

PT J
DE cell-free DNA; cell-free fetal DNA; massive parallel genomic sequencing;
   noninvasive prenatal testing
ID CELL-FREE DNA; MATERNAL PLASMA; DOWN-SYNDROME; FETAL DNA; GENETIC
   AMNIOCENTESIS; CHROMOSOMES 13; TRISOMIES 21; ANEUPLOIDY; BLOOD;
   POPULATION
ER

PT J
ER

PT J
ID ASSISTED REPRODUCTIVE TECHNOLOGY; MULTIPLE BIRTHS; DOWN-SYNDROME;
   CHROMOSOMAL ANEUPLOIDIES; NUCHAL TRANSLUCENCY; UNITED-STATES; DIAGNOSIS;
   GESTATIONS; ZYGOSITY; TRENDS
ER

PT J
ID NONINVASIVE PRENATAL-DIAGNOSIS; MATERNAL PLASMA; ANEUPLOIDY;
   ABNORMALITIES; BLOOD
ER

PT J
DE Cell-free fetal DNA; Down syndrome; Fetal aneuploidy; Non-invasive
   prenatal testing; Prenatal diagnosis
ID FREE FETAL DNA; CELL-FREE DNA; SINGLE-GENE DISORDERS; MATERNAL PLASMA;
   CLINICAL IMPLEMENTATION; WHOLE GENOME; DIAGNOSIS; ANEUPLOIDY; BLOOD;
   TRISOMY
ER

PT J
ER

PT J
DE Non-invasive prenatal testing; Cell-free fetal DNA; Fetal sex
   assessment; RhD genotyping; Fetal chromosomal aneuploidy; Single-gene
   disorders
ID CONGENITAL ADRENAL-HYPERPLASIA; TRISOMY NIFTY TEST; SEX DETERMINATION;
   HUNTINGTON-DISEASE; CHROMOSOMAL ANEUPLOIDIES; MONOGENIC DISEASES;
   EARLY-PREGNANCY; NUCLEIC-ACIDS; DIGITAL PCR; PLASMA
ER

PT J
ER

PT S
DE fetal aneuploidy; noninvasive prenatal testing; noninvasive prenatal
   screening; cell-free DNA
ID CELL-FREE DNA; FREE FETAL DNA; CONFINED PLACENTAL MOSAICISM; SERUM
   ALPHA-FETOPROTEIN; MATERNAL PLASMA; DOWN-SYNDROME;
   CHROMOSOMAL-ABNORMALITIES; INTERNATIONAL SOCIETY; CLINICAL-APPLICATION;
   ANEUPLOIDY DETECTION
ER

PT J
DE Aneuploidy; Down syndrome; Fetal diagnosis; First trimester; Noninvasive
   prenatal diagnosis; Prenatal diagnosis; Prenatal screening; Trisomy 13;
   Trisomy 18; Trisomy 21
ID MEIOTIC ERRORS; DIAGNOSIS; AGE
ER

PT S
DE Noninvasive prenatal diagnosis; Circulating fetal DNA; Plasma DNA;
   Aneuploidy detection; Down syndrome; Relative mutation dosage analysis;
   RMD; Relative haplotype dosage; RHDO
ID FREE FETAL DNA; POLYMERASE-CHAIN-REACTION; NEGATIVE PREGNANT-WOMEN;
   MATERNAL PLASMA DNA; CELL-FREE DNA; HYPERMETHYLATED RASSF1A; DIGITAL
   PCR; CHROMOSOMAL-ABNORMALITIES; SEX DETERMINATION; ALLELIC RATIO
ER

PT J
ID TWIN-TWIN TRANSFUSION; EARLY-ONSET PREECLAMPSIA; MATERNAL PLASMA;
   NONINVASIVE DETECTION; TRIAL; DNA; ABNORMALITIES; ANEUPLOIDIES;
   ANASTOMOSES; PREGNANCIES
ER

PT J
DE cell-free fetal DNA; circulating nucleic acids; Down syndrome screening;
   fetal DNA in maternal plasma; next-generation DNA sequencing;
   non-invasive prenatal testing
ID CHROMOSOMAL ANEUPLOIDY; MONOGENIC DISEASES; BETA-THALASSEMIA;
   DOWN-SYNDROME; DIGITAL PCR; DIAGNOSIS; ABNORMALITIES; PREGNANCIES;
   TRISOMIES; BLOOD
ER

PT J
ID PREECLAMPSIA
ER

PT J
DE chromosomal abnormality; noninvasive prenatal test; prenatal screening;
   trisomy 21
ID FREE FETAL DNA; COMPARATIVE GENOMIC HYBRIDIZATION; CELL-FREE DNA;
   MATERNAL PLASMA; DOWN-SYNDROME; ANEUPLOIDY DETECTION; 1ST TRIMESTER;
   NUCHAL TRANSLUCENCY; PREGNANT-WOMEN; NIFTY TEST
ER

PT J
DE noninvasive prenatal diagnosis; cffDNA; Chromosomal aneuploidies;
   maternal blond; massively parallel sequencing
ID MATERNAL PLASMA; DOWN-SYNDROME; BLOOD; ANEUPLOIDY; SERUM; AMNIOCENTESIS;
   PREECLAMPSIA; PREGNANCY; ABNORMALITIES; CLEARANCE
ER

PT J
ER

PT J
ID MATERNAL PLASMA; DOWN-SYNDROME; DNA; DIAGNOSIS; MOSAICISM; BLOOD;
   ABNORMALITIES; PREGNANCIES; AMNIOCYTES; TRISOMIES
ER

PT J
ID NONINVASIVE PRENATAL-DIAGNOSIS; PLASMA
ER

PT J
DE amniocentesis; aneuploidy; chorionic villus sampling; Down syndrome;
   fetal DNA; maternal plasma; screening; sequencing; trisomy
ID FREE FETAL DNA; CONFINED PLACENTAL MOSAICISM; CELL-FREE DNA; BALANCED
   CHROMOSOME REARRANGEMENTS; MATERNAL PLASMA; PARENTAL ORIGIN;
   DOWN-SYNDROME; X-CHROMOSOME; MESSENGER-RNA; TRISOMIES 13
ER

PT J
ID MATERNAL PLASMA; FETAL DNA; DIAGNOSIS; SERUM
ER

PT J
DE aneuploidy; cell-free fetal DNA; Down syndrome; fetal aneuploidies;
   next-generation sequencing; non-invasive prenatal diagnosis; prenatal
   screening
ID FREE FETAL DNA; NEURAL-TUBE DEFECTS; MATERNAL PLASMA; CHROMOSOMAL
   ANEUPLOIDY; WEEKS GESTATION; DOWNS-SYNDROME; DIGITAL PCR; TRISOMY-21;
   1ST-TRIMESTER; AMNIOCENTESIS
ER

PT J
ID CELL-FREE DNA; MATERNAL PLASMA; CHROMOSOMAL ANEUPLOIDY; SIZE
   DISTRIBUTIONS; DIGITAL PCR; DIAGNOSIS; TRISOMY-21; BLOOD; ABNORMALITIES;
   LIGATION
ER

PT J
ID DOWN-SYNDROME; FETAL DNA; GENOME
ER

PT J
ID MATERNAL PLASMA DNA; FETAL DNA; DIAGNOSIS; ANEUPLOIDIES
ER

PT J
ID MONOGENIC DISEASES; DNA; FETAL; DIAGNOSIS; GENOME; TRISOMY-21;
   ANEUPLOIDY; BLOOD
ER

PT J
DE Down syndrome; fetal DNA; maternal serum; non-invasive prenatal
   diagnosis; twin pregnancies
ER

PT J
DE Fetal whole genome recovery; next generation sequencing; noninvasive
   prenatal diagnosis
ID NONINVASIVE PRENATAL-DIAGNOSIS; TRISOMY-21
ER

PT J
ID FETAL DNA; NUCLEIC-ACIDS; DIAGNOSIS; SERUM; AMNIOCENTESIS; PREECLAMPSIA;
   PREGNANCIES; TRISOMY-21; BLOOD
ER

PT S
DE genome; exome; Mendelian; cancer; transplant; prenatal
ID ACUTE MYELOID-LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; CELL LUNG-CANCER;
   METHYLTRANSFERASE GENE EZH2; HUMAN-GENOME; MYELODYSPLASTIC SYNDROMES;
   HEREDITARY HEMOCHROMATOSIS; STRUCTURAL VARIATION; RECURRENT MUTATIONS;
   FREQUENT MUTATION
ER

PT J
ID MATERNAL PLASMA; DOWN-SYNDROME; DNA; 1ST-TRIMESTER
ER

PT J
ID NONINVASIVE PRENATAL-DIAGNOSIS; CHROMOSOMAL ANEUPLOIDY; DOWN-SYNDROME;
   DIGITAL PCR; GENOME; SERUM; MODEL
ER

PT J
DE circulating fetal DNA; digital PCR; massively parallel sequencing;
   noninvasive prenatal diagnosis
ID NONINVASIVE PRENATAL-DIAGNOSIS; DOWN-SYNDROME; DIGITAL PCR; CHROMOSOMAL
   ANEUPLOIDIES; PREGNANT-WOMEN; RHESUS D; FREE DNA; TRISOMY-21; RHD; READY
ER

PT J
ID PRENATAL-DIAGNOSIS; GENETICS
ER

PT J
ID FETAL ANEUPLOIDY; COUNTING ALLELES; CYSTIC-FIBROSIS; DNA; PCR;
   POPULATION; SERUM
ER

PT J
ER

PT J
DE aneuploidy; cell free fetal DNA in maternal blood; non-invasive prenatal
   diagnosis
ID CONGENITAL ADRENAL-HYPERPLASIA; DOWN-SYNDROME; NONINVASIVE
   DETERMINATION; ANEUPLOIDY DETECTION; SEX DETERMINATION; PREGNANT-WOMEN;
   NUCLEIC-ACIDS; PLASMA DNA; RHD STATUS; MUTATION
ER

PT J
DE aneuploidy; chromosomal abnormalities; non-invasive; prenatal
ID MATERNAL PLASMA; ANEUPLOIDY DETECTION; FETAL ANEUPLOIDY; DOWNS-SYNDROME;
   DIAGNOSIS; DNA; BLOOD; AMNIOCENTESIS; RISK; 1ST-TRIMESTER
ER

PT J
DE cell-free DNA (cfDNA); fetal aneuploidy; massively parallel sequencing
   (MPS); maternal plasma; non-invasive prenatal testing (NIPT)
ID BLOOD; DIAGNOSIS; ABNORMALITIES; ACCURACY
ER

PT J
ER

PT J
ID HUNTINGTONS-DISEASE; CHILDRENS COMPETENCE; CLINICAL-APPLICATION; ETHICAL
   ISSUES; TECHNOLOGY; GENETICS; EXPERIENCE; MEDICINE; CONSENT; IMPACT
ER

PT J
ER

PT J
ID MATERNAL PLASMA; FETAL DNA; PRENATAL-DIAGNOSIS; VARIANTS; INHERITANCE;
   ANEUPLOIDY; ACCURATE; DISEASE; GENES
ER

PT J
DE Down syndrome; trisomy 21; plasma nucleic acids; foetal DNA in maternal
   plasma; next-generation sequencing
ID FREE FETAL DNA; MICROSATELLITE ALTERATIONS; CHROMOSOMAL ANEUPLOIDY;
   CANCER PATIENTS; DOWN-SYNDROME; DIGITAL PCR; BLOOD; TRISOMY-21; CELLS;
   SERUM
ER

PT J
DE Down syndrome; fetal DNA; massively parallel sequencing; maternal
   plasma; prenatal diagnostics; trisomy 13; trisomy 18
ID ANEUPLOIDY; TRISOMY-21; BLOOD
ER

PT J
DE circulating nucleic acids; Down syndrome; next-generation sequencing;
   noninvasive prenatal diagnosis; plasma DNA; prenatal screening
ID NONINVASIVE PRENATAL-DIAGNOSIS; DIGITAL PCR; CHROMOSOMAL ANEUPLOIDY; DNA
   METHYLATION; MESSENGER-RNA; PLASMA; TRISOMY-21; STRATEGY; WOMEN; SERUM
ER

PT J
ER

PT J
ID PRENATAL-DIAGNOSIS; PERIPHERAL-BLOOD; PLASMA
ER

PT J
ID FREE FETAL DNA; MATERNAL PLASMA; BLOOD; ANEUPLOIDY; SERUM
ER

PT J
DE DNA; RNA; GENETIC COUNSELLING; SINGLE GENE DISORDERS; General
   cytogenetics; MATERNAL SERUM SCREENING
ID FREE FETAL DNA; MATERNAL PLASMA; DIGITAL PCR; CHROMOSOMAL ANEUPLOIDY;
   NUCLEIC-ACIDS; ALLELIC RATIO; TRISOMY-21; BLOOD; METHYLATION; MARKERS
ER

PT J
ID DOWN-SYNDROME
ER

PT J
DE DNA; FETAL CELLS; NUCLEIC ACIDS & PROTEINS; MATERNAL SERUM SCREENING;
   general cytogenetics; PRENATAL CYTOGENETICS; counseling; non-invasive;
   sequencing
ID DNA
ER

PT J
DE Hemoglobinopathies; Prenatal diagnosis; Pyrosequencing; Maternal DNA
   contamination
ID POLYMERASE-CHAIN-REACTION; BETA-THALASSEMIA; AMPLIFICATION
ER

PT J
DE Prenatal diagnosis; Aneuploidy; Monogenic diseases; Carrier testing;
   Next-generation sequencing
ID FETAL CHROMOSOMAL ANEUPLOIDY; MATERNAL PLASMA; DNA; TRISOMY-21; BLOOD
ER

PT J
ID DE-NOVO METHYLATION; METHYLTRANSFERASE EXPRESSION;
   INITIAL-CHARACTERIZATION; EPIGENETIC INHERITANCE; REPETITIVE SEQUENCES;
   PARENTAL ALLELES; DNMT3 FAMILY; HUMAN GENOME; MALE-MICE; MOUSE
ER

PT J
ID CHROMOSOMAL ANEUPLOIDY; BLOOD; 1ST-TRIMESTER; AMNIOCENTESIS; WOMEN
ER

PT J
ID ANEUPLOIDY; TRISOMY-21
ER

PT J
DE Noninvasive prenatal diagnosis; NIPD; Circulating cell-free fetal DNA;
   Massively parallel sequencing; Next-generation DNA sequencing; Maternal
   blood
ER

PT J
DE Non-invasive prenatal diagnosis; Cell-free fetal nucleic acids; Fetal
   aneuploidy; Trisomy 21; Monogenic diseases; Next-generation sequencing
ID CONGENITAL ADRENAL-HYPERPLASIA; DIGITAL PCR; CHROMOSOMAL ANEUPLOIDY; SEX
   DETERMINATION; POSITIVE CONTROL; DNA ANALYSIS; BLOOD; TRISOMY-21;
   THALASSEMIA; 1ST-TRIMESTER
ER

PT J
ID DOWNS-SYNDROME; FETAL DNA; 1ST-TRIMESTER; DIAGNOSIS; SERUM
ER

PT J
ID HUMAN GENOME; TAY-SACHS; DNA; ANEUPLOIDY; DIAGNOSIS
ER

PT J
DE DNA; RNA; fetal cells; nucleic acids and proteins; single gene
   disorders; genomics; DNA sequencing; digital genotyping
ID NONINVASIVE PRENATAL-DIAGNOSIS; CHROMOSOMAL ANEUPLOIDY; DIGITAL PCR;
   BLOOD
ER

PT J
ID PRENATAL-DIAGNOSIS; NUCLEIC-ACIDS; DNA; CANCER; BLOOD; RNA
ER

PT J
ID NONINVASIVE PRENATAL-DIAGNOSIS; FETAL DNA; ANEUPLOIDY; BLOOD; SERUM
ER

PT J
DE chromosomal aneuploidy; monogenic disease; plasma DNA; next-generation
   sequencing; massively parallel sequencing; genomics
ID FETAL CHROMOSOMAL ANEUPLOIDY; MATERNAL PLASMA; DNA; DOSAGE; SERUM
ER

PT J
DE cytogenetics; array CGH; SNP arrays; DNA sequencing; structural
   variation; copy number variants
ID COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; ARRAY-CGH;
   IMBALANCES; DNA
ER

PT J
DE epigenomics; prevention of chromosome abnormalities; genetic treatment
ID EPIGENOMICS
ER

PT J
ID DIAGNOSIS; DNA; GENOME; SERUM
ER

PT J
ID COPY-NUMBER CHANGES; GENE; REARRANGEMENTS; MUTATIONS
ER

PT J
ID NONINVASIVE PRENATAL-DIAGNOSIS; MATERNAL PLASMA; CHROMOSOMAL ANEUPLOIDY;
   DNA; BLOOD
ER

PT J
DE circulating cell-free fetal DNA; maternal plasma; noninvasive prenatal
   diagnosis; prenatal diagnosis; RhD; single-gene disorder
ID FREE FETAL DNA; CONGENITAL ADRENAL-HYPERPLASIA; CELL-FREE DNA;
   SINGLE-NUCLEOTIDE POLYMORPHISMS; REAL-TIME PCR; HUNTINGTON-DISEASE;
   CHROMOSOMAL ANEUPLOIDY; FORMALDEHYDE TREATMENT; SEX DETERMINATION; POINT
   MUTATIONS
ER

PT J
ID PLASMA; SERUM; RNA
ER

PT J
DE circulating nucleic acids; maternal plasma; genetic digital PCR;
   next-generation sequencing; molecular prenatal diagnostics
ID TOF MASS-SPECTROMETRY; CELL-FREE DNA; BETA-THALASSEMIA; DIGITAL PCR;
   CHROMOSOMAL ANEUPLOIDY; FORMALDEHYDE TREATMENT; QUANTITATIVE-ANALYSIS;
   SIZE FRACTIONATION; HUNTINGTON DISEASE; POINT MUTATIONS
ER

PT J
DE QF-PCR; chromosome X aneuploidies; amelogenin; DNA; fetal cells; nucleic
   acids and proteins; general cytogenetics; prenatal cytogenetics; genetic
   counseling
ID QUANTITATIVE FLUORESCENT PCR; RAPID DETECTION; QF-PCR; ANEUPLOIDIES;
   CHROMOSOME; DNA
ER

PT J
DE hemophilia; DNA inversions; prenatal diagnosis; IS-PCR
ID FACTOR-VIII GENE; INTRON-1
ER

PT J
DE fetal DNA in maternal plasma; fluorescence amplifying slides;
   microarray; non-invasive prenatal diagnosis
ID NONINVASIVE PRENATAL-DIAGNOSIS; CIRCULATING NUCLEIC-ACIDS;
   BETA-THALASSEMIA; DNA
ER

PT J
ID FETAL CHROMOSOMAL ANEUPLOIDY; MATERNAL PLASMA; DIGITAL PCR;
   NUCLEIC-ACIDS; DNA-METHYLATION; FUTURE-PROSPECTS; DOWNS-SYNDROME; BLOOD;
   SERUM; FORMALDEHYDE
ER

PT J
ID NONINVASIVE PRENATAL-DIAGNOSIS; MATERNAL PLASMA; CIRCULATING DNA; FETAL
   DNA; QUANTITATIVE-ANALYSIS; NUCLEIC-ACIDS; SERUM; METHYLATION;
   ANEUPLOIDY
ER

PT J
DE Down syndrome; Solexa sequencing; trisomy 21
ID PLACENTAL ORIGIN; MESSENGER-RNA; DIGITAL PCR; BLOOD; AMNIOCENTESIS;
   TRISOMY-21; CELLS; WOMEN; SERUM
ER

PT J
DE fetal DNA; next-generation sequencing; noninvasive prenatal diagnosis;
   Down syndrome; trisomy
ID PRENATAL-DIAGNOSIS; PREGNANT-WOMEN; DOWNS-SYNDROME; HUMAN GENOME;
   PLASMA; CELLS; 1ST-TRIMESTER; CANCER; SERUM; PCR
ER

PT J
DE non-invasive prenatal diagnosis; fetal DNA in maternal plasma;
   PNA-clamping
ID SINGLE-NUCLEOTIDE POLYMORPHISMS; CELL-FREE DNA; MATERNAL PLASMA;
   MUTATION DETECTION; GENETIC-DISEASES; FETAL DNA; PNA; CHIP; PCR
ER

PT J
ID TRANSPORTER ABCA12; MUTATIONS; DIAGNOSIS
ER

PT J
DE beta-thalassemia; Egypt; prenatal diagnosis; outcome
ID REFRACTORY MUTATION SYSTEM; DNA
ER

PT J
DE cell-free fetal DNA; DNA methylation; Down syndrome; epigenetic;
   non-invasive prenatal diagnosis; real-time polymerase chain reaction
ID MATERNAL PLASMA; FETAL DNA; NUCLEIC-ACIDS; METHYLATION PATTERN; CELLS;
   ORIGIN; BLOOD; SERUM; CIRCULATION; SYSTEM
ER

PT J
ID DIAGNOSIS; DNA
ER

PT J
DE prenatal diagnosis; polymerase chain reaction; fetal DNA; short tandem
   repeat
ID BLOOD; CELLS; SERUM; POLYMORPHISMS; PREGNANCY; PERSIST; PCR
ER

PT J
ID PREGNANT-WOMEN; PREECLAMPSIA; TIME; FETUSES
ER

PT J
DE beta-thalassemia (thal); reverse dot-blot; prenatal diagnosis
ID MUTATIONS; POPULATION; PREVALENCE; SPECTRUM; DNA
ER

PT J
ID ULTRASOUND DIAGNOSIS; DYSOSTOSIS
ER

PT J
DE fetal DNA; haemophilia; pregnancy; prenatal diagnosis
ID DNA; PLASMA; PREGNANCY; PERSIST; SERUM
ER

PT J
DE holocarboxylase synthetase; prenatal diagnosis; molecular diagnosis
ID MULTIPLE CARBOXYLASE DEFICIENCY; BIOTIN THERAPY; ONSET; MUTATION;
   DEFECT; GENE
ER

PT J
DE DMD; carrier analysis; semiquantitative PCR
ID DUCHENNE MUSCULAR-DYSTROPHY; POLYMERASE CHAIN-REACTION; FEMALE CARRIERS;
   DELETIONS; IDENTIFICATION; DUPLICATIONS; DMD/BMD; MLPA; PCR
ER

PT J
DE DNA methylation; noninvasive prenatal diagnosis; circulating nucleic
   acids
ID POLYMERASE-CHAIN-REACTION; FETAL DNA CONCENTRATIONS; PRENATAL-DIAGNOSIS;
   QUANTITATIVE-ANALYSIS; MESSENGER-RNA; METHYLATION; SERUM; PREECLAMPSIA;
   ORIGIN; STRATEGY
ER

PT J
DE tuberous sclerosis; prenatal diagnosis; rhabdomyoma; gene mutation
ID CARDIAC TUMORS; FETAL; IDENTIFICATION; MUTATION; COMPLEX; RHABDOMYOMAS;
   MARKER; FETUS; 9Q34
ER

PT J
DE gene mutation; prenatal diagnosis; xeroderma pigmentosum group A
ID MICE LACKING; POINT MUTATION; ULTRAVIOLET-B; XPAC GENE; PCR
ER

PT J
DE hereditary spastic paraplegia; HSP; SPG4; prenatal diagnosis
ID PROTEIN; FAMILIES
ER

PT J
ER

PT J
DE beta-thalassemia; mutation analysis; Iran
ID SPECTRUM
ER

PT J
DE beta thalassemia; DNA maternal contamination; HLA SSP-PCR; prenatal
   diagnosis
ID POLYMERASE CHAIN-REACTION; CELL CONTAMINATION; POLYMORPHIC LOCUS; PCR
   AMPLIFICATION; CHORIONIC VILLI; SEQUENCE
ER

PT J
DE EEC syndrome; genodermatosis; p63 gene mutation; prenatal diagnosis
ID P53 HOMOLOG
ER

PT J
DE Netherton syndrome; prenatal diagnosis; SPINK5; serine protease
   inhibitor Kazal-type 5; lympho-epithelial Kazal-type related inhibitor
ID INHIBITOR; SKIN
ER

PT J
DE D-bifunctional protein deficiency; peroxisomal disorder; prenatal
   diagnosis; peroxisomal beta-oxidation defect; peroxisomes
ID CHAIN FATTY-ACIDS; DISORDERS; IV
ER

PT S
DE cell-free DNA; transplant; graft rejection
ID MATERNAL PLASMA; FETAL DNA; EXTRACELLULAR DNA; BLOOD; ERYTHROBLASTS;
   RECIPIENTS; MULTIPLEX; SERUM
ER

PT J
DE prenatal diagnosis; thalassemia; polymerase chain reaction (PCR);
   high-throughput sequencing
ID POLYMERASE CHAIN-REACTION; BETA-GLOBIN GENE; HYDROPS-FETALIS; SEQUENCE;
   PCR
ER

PT J
DE prenatal diagnosis; epidermolysis bullosa simplex; keratin 14; mutation
   detection
ID HELIX TERMINATION PEPTIDE; DOWLING-MEARA; MUTATION; KERATIN-5; GENE;
   DOMAIN; IDENTIFICATION; AMPLIFICATION; SEQUENCE; VARIANT
ER

PT S
ID ACID DEHYDROGENASE COMPLEX; E1-ALPHA LOCUS; MESSENGER-RNA
ER

PT S
ID PRENATAL-DIAGNOSIS; SERUM; PCR
ER

PT J
DE prenatal diagnosis; primary immunodeficiency; Wiskott-Aldrich syndrome;
   chorionic villus sampling; SSCP; mutation analysis
ID X-LINKED THROMBOCYTOPENIA; WASP GENE; CELLS
ER

EF